SCHEMBL10746688

SCHEMBL10746688

S=c1c2ccccc2[se]n1-c1cnccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ METAP2 P50579 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ QSOX1 O00391 1/20 0.35
▸ RGS12 O14924 1/20 0.35
▸ PMM2 O15305 1/20 0.35
▸ PLIN1 O60240 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ BBOX1 O75936 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYBB P04839 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ G6PD P11413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502474 0.83 ALDH1A1 (0.38) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL5916796 0.82 METAP2 (0.53) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10502592 0.77 ALDH1A1 (0.42) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10501684 0.77 SMN1; SMN2 (0.45) KDM4ELMNAMETAP2ALDH1A1GLA
SCHEMBL10501411 0.77 METAP2 (0.38) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10747582 0.76 METAP2 (0.40) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10501733 0.75 METAP2 (0.36) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10501746 0.75 METAP2 (0.43) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10502470 0.74 METAP2 (0.46) KDM4ELMNAMETAP2MEN1QSOX1
SCHEMBL10747607 0.72 KDM4E (0.41) KDM4ELMNAMETAP2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback